«Clexane" is widely used in cardiology, orthopedics, surgery and traumatology to reduce blood clotting, that is, to prevent the formation of blood clots.The drug is available in packages for single-syringe injection, this form of release is very useful in the care of immobile patients and the provision of emergency aid in emergency situations.

Features of the drug

Apply "Clexane" without a prescription is impossible.Determine its own dosage is impossible, as it is calculated for each case, in accordance with the results of blood tests and the characteristics of the disease.Throughout the course of treatment is carried out regularly control of blood platelet number in it, and general health of the patient.

introduction of a sp
ecific drug, know how to inject properly and how to apply the "Clexane" can only be a health worker.The drug is administered subcutaneously in the abdomen, the patient must lie.The needle is inserted vertically to its entire length in the holding fingers skin fold, which can not be disclosed to the full implementation of the contents of the syringe.Self-treatment or unprofessional performance of injection can lead to organ damage and other negative effects, life-threatening.

Indications "Clexane»

The drug is indicated for the treatment and prevention of thrombosis in bedridden patients with cardiac and respiratory failure after acute heart attacks, unstable angina, as well as the prevention of blood clots in the blood vessels in the postoperative period, whenvarices.


«Clexane" can not be used in the treatment of stroke patients, in case of an aortic aneurysm or cerebral vessels, pregnant women with threatened miscarriage or suspected placental abruption and women who have recently undergone childbirth any complexity.Under the constant supervision of the state of the blood and supervision of a physician are treated with medication for suspected violations of hemostasis, liver or kidney failure, hypertension and gastrointestinal disease.In addition, it is impossible to mix drug treatment with hormonal therapy or contraception, is inadmissible its application to patients older than 75 years and with signs of obesity or malignant tumors oncological nature.